Vesicular Monoamine Transport Proteins
"Vesicular Monoamine Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.
| Descriptor ID |
D050493
|
| MeSH Number(s) |
D12.776.157.530.450.162.887.500.500 D12.776.157.530.562.750.500.500 D12.776.543.585.450.162.887.500.500 D12.776.543.585.562.750.500.500
|
| Concept/Terms |
Vesicular Monoamine Transport Proteins- Vesicular Monoamine Transport Proteins
- Vesicular Monoamine Transporter Proteins
- Monoamine Vesicular Transporter
- Vesicular Transporter, Monoamine
- Vesicular Monoamine Transporter
- Monoamine Transporter, Vesicular
- Monoamine Transporters, Vesicular
- Vesicular Monoamine Transporters
- Monoamine Vesicular Transport Proteins
Vesicular Monoamine Transporter 1- Vesicular Monoamine Transporter 1
- VMAT-1 Vesicular Monoamine Transporter
- VMAT 1 Vesicular Monoamine Transporter
- Chromaffin Granule Amine Transporter
|
Below are MeSH descriptors whose meaning is more general than "Vesicular Monoamine Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Vesicular Monoamine Transport Proteins".
This graph shows the total number of publications written about "Vesicular Monoamine Transport Proteins" by people in this website by year, and whether "Vesicular Monoamine Transport Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vesicular Monoamine Transport Proteins" by people in Profiles.
-
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. J Neurochem. 2013 Oct; 127(2):187-98.
-
Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. Pharmacogenet Genomics. 2012 Apr; 22(4):254-60.
-
Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology. 2011 Sep; 61(4):849-56.
-
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol. 2008 Jul; 198(1):41-9.
-
Identification of tissue-restricted transcripts in human islets. Endocrinology. 2004 Oct; 145(10):4513-21.
-
Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2. Endocrinology. 2001 Aug; 142(8):3663-72.